-
2024-519087-41-00
5
Breast cancer is the most common form of cancer among women in North A
-
2025-520466-22-00
5
2026-04-29
Advanced Platinum-resistant Epithelial Ovarian Cancer
-
2025-521142-22-00
5
2026-03-27
Hereditary Angioedema
-
2025-521293-34-00
4
2025-12-09
Moderate-to-severe hidradenitis suppurativa
-
2023-509810-13-00
4
2023-05-13
Acute Lymphoblastic Leukemia (ALL)
-
2025-523015-11-00
5
2026-03-18
Pericarditis
-
2024-518895-30-00
4
2025-11-21
PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA
-
2025-521660-35-00
5
2025-09-11
Hereditary Angioedema
-
2024-517247-31-00
5
2025-07-07
Newly Diagnosed Higher Risk Myelodysplastic Syndrome
-
2024-517504-11-00
5
2025-01-29
Pregnant patients diagnosed with premature rupture of membranes (PROM)
-
2024-519310-31-00
4
2025-01-27
Anemia due to MDS with del5q with IPSS-R very low, low, or intermediat
-
2024-514656-32-00
4
2025-01-23
Suspected or confirmed Gram negative infections
-
2023-509717-36-00
5
2024-12-16
AF patients who have undergone successful PCI
-
2024-516839-27-00
4
2024-12-09
BRCA wild-type advanced ovarian, fallopian tube and primitive peritone
-
2024-518092-62-00
5
2024-12-09
Adult critically ill patients requiring non-invasive (NIMV) or invasiv
-
2024-517863-22-00
5
2024-12-01
Study population consists in patients with a diagnosis of mCRC who hav
-
2024-514917-36-00
5
2024-11-21
Patients with High Risk Neuroblastoma
-
2024-517407-36-00
4
2024-11-12
Patients admitted to an IVF/ICSI cycle will be included. The patient w
-
2023-504169-22-02
5
2024-07-31
Severe cardiac inflammation
-
2023-509551-14-00
5
2024-06-12
Unresectable left sided RAS/B-RAF wild-type metastatic colorectal canc
-
2024-516563-86-00
4
2024-04-11
Spinal and Bulbar Muscular Atrophy
-
2024-514139-50-00
5
2022-11-14
Multiple myeloma
-
2024-512322-28-00
5
2022-10-25
Low Grade Upper Tract Urothelial Cancer
-
2024-518909-18-00
5
2021-03-23
HIV-1 infected individuals currently taking an INSTI-based three-drug